571 related articles for article (PubMed ID: 21060154)
1. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
2. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination.
Yan J; Di Y; Shi H; Rao H; Huo K
FEBS Lett; 2010 Oct; 584(20):4319-24. PubMed ID: 20849854
[TBL] [Abstract][Full Text] [Related]
4. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
6. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.
Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
8. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
Yang G; Gong Y; Wang Q; Wang L; Zhang X
Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
[TBL] [Abstract][Full Text] [Related]
9. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
10. PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2.
Choy MK; Movassagh M; Bennett MR; Foo RS
J Cell Physiol; 2010 Mar; 222(3):635-9. PubMed ID: 19950214
[TBL] [Abstract][Full Text] [Related]
11. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
[TBL] [Abstract][Full Text] [Related]
12. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D
FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840
[TBL] [Abstract][Full Text] [Related]
13. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.
Huang C; Wu S; Ji H; Yan X; Xie Y; Murai S; Zhao H; Miyagishi M; Kasim V
Sci Adv; 2017 Oct; 3(10):e1701383. PubMed ID: 29057323
[TBL] [Abstract][Full Text] [Related]
14. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J; Xie P; Liu L; Xing G; Chang Z; Yin Y; Tian C; He F; Zhang L
J Biol Chem; 2010 Jul; 285(30):22818-30. PubMed ID: 20484049
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
16. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
17. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.
Jin Y; Zeng SX; Sun XX; Lee H; Blattner C; Xiao Z; Lu H
Mol Cell Biol; 2008 Feb; 28(4):1218-29. PubMed ID: 18086887
[TBL] [Abstract][Full Text] [Related]
18. Critical role for Daxx in regulating Mdm2.
Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
Liu S; Tackmann NR; Yang J; Zhang Y
Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
[TBL] [Abstract][Full Text] [Related]
20. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1.
Reuther C; Heinzle V; Nölting S; Herterich S; Hahner S; Halilovic E; Jeay S; Wuerthner JU; Aristizabal Prada ET; Spöttl G; Maurer J; Auernhammer CJ
Neuroendocrinology; 2018; 106(1):1-19. PubMed ID: 27871087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
